Background Electric bicycle (e-bike) injury incidence and severity are increasing. While prior studies describe e-bike injuries and outcomes, there remains limited synthesis linking injury patterns and healthcare burden to contextual determinants such as the built and social environment, rider demographics, and e-bike safety policies. This review addresses this gap by integrating epidemiologic findings with prevention-relevant context using a Haddon Matrix framework. Methods We conducted a systematic review (PROSPERO-registered), searching MEDLINE, Embase, CINAHL, Scopus, and the Cochrane Library to June 2, 2025. Eligible studies reported e-bike-related injury data and at least three additional e-bike-specific elements drawn from these 4 domains: injury context, severity, treatment, and outcomes. Two reviewers independently screened records, extracted data, and assessed study quality using the Newcastle-Ottawa Scale (NOS). Findings were synthesized narratively and stratified by country, with pooled descriptive summaries reported where feasible. Results Thirty-five studies met inclusion criteria, representing 23 unique datasets (6107 cases) from six countries. Injuries predominantly involved the head (18%-65.7%) and extremities (6.4%-74%). Pooled outcome estimates indicated substantial healthcare utilization, including surgical intervention (31.6%), ICU admission (13.1%), and mortality (1.64%). Single-vehicle injuries were frequently reported. Helmet use varied widely by setting, ranging from 1% to 1.7% in the Netherlands to 63%-73.1% in Switzerland, reflecting differences in policy and cycling culture. Reported prevention strategies most commonly emphasized helmets/protective equipment, education and training, enforcement/legislation, and infrastructure-based interventions. Based on NOS, 48.6% of studies were considered good quality, 11.4% fair, and 40.0% poor. Discussion E-bike injury profiles vary substantially across countries, consistent with differing rider demographics, crash scenarios, infrastructure, and regulatory contexts. Prevention will likely require context-specific, multi-component strategies and stronger surveillance and standardized reporting to support rigorous intervention evaluation.
No takes yet. Share an insight, caveat, or question.
Lam et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: